Navigation Links
Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
Date:4/22/2008

Findings Include 80% SVR12 Rate with Nitazoxanide-Based Combination Therapy

and New Insights into Mechanism of Action of Nitazoxanide

MILAN, Italy, April 23 /PRNewswire/ -- Romark Laboratories, a privately held biopharmaceutical company, today announced that data from studies of nitazoxanide in chronic hepatitis C virus (HCV) infection are being communicated in four presentations made at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), held in Milan, Italy this week.

"These new studies confirm earlier data suggesting synergistic activity between nitazoxanide and peginterferon in genotype 4 patients and provide a first look at sustained virologic response in a limited number of genotype 1 patients," said Jean-Francois Rossignol, M.D., Director of the Romark Institute for Medical Research and discoverer of nitazoxanide. "These data also provide interesting insights into the mechanism of action of nitazoxanide and confirm previous findings related to its safety."

The four presentations include:

-- An oral presentation, titled, "Randomized Controlled Trial of

Nitazoxanide-Peginterferon-Ribavirin, Nitazoxanide-Peginterferon and

Peginterferon-Ribavirin in the Treatment of Patients with Chronic

Hepatitis C Genotype 4," reported final 24-week post-treatment

sustained virologic response (SVR) rates for the company's STEALTH C-1

trial.

In the trial, 96 treatment-naive patients with chronic hepatitis C

genotype 4 were randomized into three groups to receive either 48 weeks

of standard of care (SOC) treatment (n=40), 12 weeks of nitazoxanide

followed by 36 weeks of nitazoxanide plus peginterferon (a dual regimen,

n=28), or 12 weeks of nitazoxanide followed by 36 weeks of nitazoxanide

plus SOC with peginterferon plus ribavirin (a triple regimen, n=28). An

additional 24 interferon-experi
'/>"/>

SOURCE Romark Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Romark Laboratories Raises $18 Million in Institutional Financing
3. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Johnson & Johnson (NYSE: JNJ ... third party to review requests made to the Janssen ... for compassionate use of its investigational medicines. This new ... a single Janssen investigational medicine and, if successful, will ... across Johnson & Johnson. In keeping with ...
(Date:5/6/2015)... , May 6, 2015  Zimmer Holdings, Inc. (NYSE and ... that it will be presenting at the Bank of America ... hotel in Las Vegas, Nevada on ... A live webcast of the presentation can be accessed ... webcast will be archived for replay following the conference. ...
(Date:5/6/2015)... 6, 2015  The fairness of the proposed acquisition ... Alexion Pharmaceuticals, Inc. ("Alexion") is being investigated by WeissLaw ... for possible breaches of fiduciary duty and other violations ... for agreeing to sell the Company to Alexion.  On ... for Alexion to acquire GEVA in a transaction valued ...
Breaking Medicine Technology:Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 2Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 3Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 4Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 5WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2
... Radient Pharmaceuticals Corporation (OTCQX: RXPC.PK - News ... developer and marketer of cancer tests, today announces it ... in Taipei, Taiwan. Previously, Radient,s agreement with ... Radient,s flagship product Onko-Sure® cancer test in Taiwan.  Radient ...
... Dec. 21, 2011  Shareholders of Medco Health Solutions, Inc. (NYSE: ... Express Scripts. (Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO ) ... vote present in person or by proxy at a special ... Merger dated July 20, 2011 by a margin of 99 ...
Cached Medicine Technology:Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits 2Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits 3Medco Shareholders Approve Merger With Express Scripts 2
(Date:5/6/2015)... MJNational LLC strengthens its consultant agreement ... Bizcard ™ platform. This exciting new SMS platform creates ... Sales / Services. Now you can reach out ... products, services and ticker symbol through an easy to ... LLC will provide managed support and services to advance ...
(Date:5/6/2015)... Sulphur Springs, Texas (PRWEB) May 06, 2015 ... the stages of the HIMSS EMR Adoption Model, ... remove paper, improve patient engagement and automate processes. ... had transitioned from paper-driven to electronic workflows, patient ... to hard copies of consents. With HIMSS Stage ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child neglect, ... in Florida while under the influence of Flakka, according to ... released by CBS4’s Peter D’Oench records Doby distraught in a ... around one year old. The drug treatment center in Florida ... named. The residents polled by CBS Miami express concern about ...
(Date:5/6/2015)... Va. (PRWEB) May 06, 2015 ... in the state of Virginia to acquire Intuitive ... surgical robot. The system upgrade includes enhanced surgical ... minimally invasive procedures across a wide spectrum of ... options, reduced pain and quicker recovery times. , ...
(Date:5/6/2015)... Baptist Medical Center Jacksonville and the ... Florida and southeast Georgia region offering MAKOplasty® Hip ... total hip replacement surgery performed using the RIO® ... enables the accurate alignment and positioning of implants. ... partial knee resurfacing using the RIO system since ...
Breaking Medicine News(10 mins):Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 2Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 3Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4
... researchers report 80 percent success with their method, , ... that they,ve developed ways to detect 80 percent of ... more than one in 10 women who give birth. ... would make it possible to intervene to prevent it ...
... FAIRFAX, Va.The Society of Interventional Radiology Foundation recently ... a future scholarship fund for interventional radiology fellows ... dedicated to advancing the clinical needs of interventional ... conducting pivotal basic and clinical trials research. ...
... 2009 Late-breaking data from SPIRIT IV, a large-scale ... shows that an everolimus-eluting stent demonstrated enhanced safety and ... artery lesions when compared to a paclitaxel-eluting stent, and ... drug-eluting stents without sacrificing safety. Unlike similar ...
... conducted by Dr. Eric Blough and his colleagues at ... pain reliever acetaminophen may help prevent age-associated muscle loss ... may affect the regulation of protein kinase B (Akt), ... regulation of cellular survival, proliferation and metabolism. The ...
... influenza could slow growth in key industries and stall already-weak ... says a health economist in the University of Alabama at ... vitally important sectors in the economy of many U.S. cities ... the spread of the virus, consumers and businesses may respond ...
... ... External services for pharmaceutical firms have shown consistent growth in recent ... The global share of biotechnology services spending is in the billions ... of high-quality external services available to pharma ranges from supportive IT, ...
Cached Medicine News:Health News:Predicting Postpartum Depression May Be Possible 2Health News:Society of Interventional Radiology Foundation receives $1 million legacy gift 2Health News:SPIRIT IV trial shows everolimus stent sets new standard for event-free survival 2Health News:Research shows safe dosages of common pain reliever may help prevent conditions related to aging 2Health News:Swine flu could wreak more havoc on US economy, says UAB economist 2Health News:Cambridge Healthtech Institute and Bio-IT World Launch a New eNewsletter: Pharma Services News 2
... duet Signature Series multipurpose gamma ... FDG imaging applications. The system uniquely combines ... the features and flexibility of modern day ... unit.,The e.cam duet maximizes camera ...
In Stainless steel. Available in 1.5, 2.0,3.0 & 3.5 MM...
... AXIOM Artis FA is ... C-arm system whose flexible ... for vascular and non-vascular ... provides complete ergonomic system ...
.60 x 22mm, angled 60, .33mm end port [Simcoe]...
Medicine Products: